Evidence map›Paper›PMID 42900882›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2026

Does treatment of non-obstructing nephrolithiasis reduce recurrent urinary tract infections? A prospective, observational trial from the EDGE consortium.

Connor M Forbes, Karen L Stern, Jamie Finegan, Amy Reed, Gopal Narang, Kevin Wymer, Jonathan Moore, Jonathan Berger, Jonathan Katz, Kimberly Maciolek and 7 more

Abstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Connor M ForbesVancouver General & University of British Columbia Hospitals, Vancouver, BC, Canada.
Karen L SternMayo Clinic Arizona, Phoenix, AZ, United States.
Jamie FineganUniversity of California San Diego, San Diego, CA, United States.
Amy ReedVanderbilt University Medical Center, Nashville, TN, United States.
Gopal NarangUniverity of North Carolina, Department of Urology, Chapel Hill, NC, United States.
Kevin WymerMayo Rochester, Rochester, MN, United States.
Jonathan MooreDalhousie University, Department of Urology, Halifax, NS, Canada.
Jonathan BergerUniversity of California San Diego, San Diego, CA, United States.
Jonathan KatzUniversity of California San Diego, San Diego, CA, United States.
Kimberly MaciolekVanderbilt University Medical Center, Nashville, TN, United States.
Tatsuki KoyamaVanderbilt University Medical Center, Nashville, TN, United States.
Aaron LeeVanderbilt University Medical Center, Nashville, TN, United States.
Ben H ChewVancouver General & University of British Columbia Hospitals, Vancouver, BC, Canada.
Nicole L MillerMayo Clinic Arizona, Phoenix, AZ, United States.
Seth K BechisDalhousie University, Department of Urology, Halifax, NS, Canada.
Roger L SurDalhousie University, Department of Urology, Halifax, NS, Canada.
Ryan S HsiMayo Clinic Arizona, Phoenix, AZ, United States.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
NCATS NIH HHS UL1 TR002243
6 · The paper itself

Abstract

introductionExisting studies link kidney stone treatment to reduced recurrent urinary tract infections (UTIs); however, these studies are limited by their retrospective design and/or lack of comparison group. The present study assesses a prospective, observational cohort of patients with recurrent UTIs who selected observation or intervention for management of their non-obstructing kidney stones to assess for impact on UTI recurrence.

methodsFrom 2020-2025, patients with non-obstructing kidney stones and recurrent UTIs were prospectively enrolled at four centers. After shared decision-making, participants underwent observation or surgical intervention. The primary outcome was UTI recurrence at 12 months post-enrollment, defined as presence of urinary tract symptoms with positive urine culture. The study was powered to detect a 50% reduction in the rate of UTI recurrence between the groups at 12 months.

resultsAmong 94 patients recruited, followup data at 12 months was available for 21 observation and 46 intervention patients. There were more staghorn stones in the intervention group (15.2% vs. 0%), and the median stone size was larger (13.5 vs. 6 mm). At 12 months, 81% (n=17) in the observation group and 54% (n=25) in the intervention group had a symptomatic UTI recurrence (p=0.06, non-significant). The subgroup (n=17) of stone-free intervention patients had fewer UTI recurrences compared to the observation group (odds ratio 0.12, 95% confidence interval 0.02-0.66). Causation cannot be confirmed due to the observational nature of the study.

conclusionsFor patients with recurrent UTIs and stones, surgical intervention is not associated with decreased risk of UTI recurrence at 12 months overall; however, patients who were stone-free after intervention had significantly fewer UTI recurrences on subgroup analysis.

Identifiers

PMID42900882
PMCPMC13660807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.